190 related articles for article (PubMed ID: 19962254)
21. Progestins and breast cancer.
Pasqualini JR; Paris J; Sitruk-Ware R; Chetrite G; Botella J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):225-35. PubMed ID: 9699877
[TBL] [Abstract][Full Text] [Related]
22. The SEEM: selective estrogen enzyme modulators in breast cancer.
Pasqualini JR; Ebert C; Chetrite GS
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():1-8. PubMed ID: 10862262
[TBL] [Abstract][Full Text] [Related]
23. Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast. A hypothesis.
Pasqualini JR; Chetrite GS
Anticancer Res; 2007; 27(5A):3219-25. PubMed ID: 17970064
[TBL] [Abstract][Full Text] [Related]
24. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
Pasqualini JR; Schatz B; Varin C; Nguyen BL
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
[TBL] [Abstract][Full Text] [Related]
25. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
26. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
Brooks JD; Thompson LU
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
[TBL] [Abstract][Full Text] [Related]
27. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
28. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
29. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
[TBL] [Abstract][Full Text] [Related]
30. Oestrogen producing enzymes and mammary carcinogenesis: a review.
Subramanian A; Salhab M; Mokbel K
Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
[TBL] [Abstract][Full Text] [Related]
31. Pomegranate and breast cancer: possible mechanisms of prevention.
Sturgeon SR; Ronnenberg AG
Nutr Rev; 2010 Feb; 68(2):122-8. PubMed ID: 20137057
[TBL] [Abstract][Full Text] [Related]
32. Sex steroid-producing enzymes in human breast cancer.
Suzuki T; Miki Y; Nakamura Y; Moriya T; Ito K; Ohuchi N; Sasano H
Endocr Relat Cancer; 2005 Dec; 12(4):701-20. PubMed ID: 16322318
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
34. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
35. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.
Sasano H; Nagasaki S; Miki Y; Suzuki T
Ann N Y Acad Sci; 2009 Feb; 1155():76-9. PubMed ID: 19250194
[TBL] [Abstract][Full Text] [Related]
36. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
Chetrite GS; Paris J; Shields-Botella J; Philippe JC; Pasqualini JR
Anticancer Res; 2003; 23(6C):4651-5. PubMed ID: 14981909
[TBL] [Abstract][Full Text] [Related]
37. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
38. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
39. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
40. Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications.
Pasqualini JR; Chetrite GS
Horm Mol Biol Clin Investig; 2012 Apr; 9(1):25-63. PubMed ID: 25961352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]